Credit Suisse Upgrades Biogen (BIIB) to Outperform
Tweet
Share
E-mailGet Alerts BIIB Hot Sheet
Price: $111.49 +0.69%
Rating Summary:
12 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Rating Summary:
12 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Join SI Premium – FREE
Credit Suisse upgraded Biogen (NASDAQ: BIIB) from Neutral to Outperform. PT increased from $100 to $126.
For more ratings news on Biogen click here and for the rating history of Biogen click here.
Shares of Biogen closed at $98.65 yesterday.
For more ratings news on Biogen click here and for the rating history of Biogen click here.
Shares of Biogen closed at $98.65 yesterday.
Create E-mail Alert Related Categories
UpgradesRelated Entities
Credit SuisseSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
